Gemer Ofer

Prof Gemer Ofer

Medical Education

Faculty of Health Sciences, Ben Gurion University of the Negev

Specialty

Obstetrics and Gynecology

  [email protected] 

Positions

¥ Head of the Gynecology Departement

¥ Director of Endoscopic Gynecology

¥ Professor in Obstetrics and Gynecology, Faculty of Health Sciences, Ben Gurion University

¥ Chairman of the Israel Society of Gynecological Oncology

Clinical Experience

« 1991-1997- Residency in Obstetrics and Gynecology, Barzilai Medical Center

« 1997-2002- Senior Physician, Obstetrics and Gynecology Department, Barzilai Medical Center

« 2002- 2010 Deputy Head, The Division of Obstetrics and Gynecology, Barzilai Medical Center

« 2010-2023 Director of Endoscopic Gynecology

« 2023- Current Head of the Gynecology Department        
 

Continuing Medical Education

³ 2004 Memorial Sloan Kettering Cancer Center, NY

³ 2006 Department of Gynecology Charité- Berlin

³ 2009 National Hospital Organization, Kyoto Medical Center, Kyoto

³ 2015 Kurashiki Medical Center , Kurashiki, Japan

³ 2016 IRCAD, Strasbourg, France

Membership in Professional Organizations in Israel and Abroad 

« Israel Medical Association

« State Organizaiton of Physicians

« Israeli Society Obstetrics and Gynecology

« Israeli Society of Colposcopy and cervical Pathology

« Israeli Society the Endoscopic Gynecology 

« Israeli Society of Oncologic Gynecology

« American Society of Gynecological Endoscopy

« International Onco-gynecology Society
 
Membership in Local and International Committees

« Member of the Israeli Society for Onco-gynecology

« Member of the Examining Committee for specialization in Gynecology and Obstetrics – the Israel « Medical Council for

Scientific Publications

More than 125 publications in the local and international medical journals have been published so far.

Publications of special interest 

1. Gemer O, Namazov A, Ben-Arie A, Eitan R, Rabinovich A, Vaknin Z, Armon S, Bruchim I, Levy T, Ben Shachar I, Lavie O. Predicting the rate of adjuvant postoperative chemo/radiation in cervical cancer with tumor size ≥2 cm and <4 cm: An Israeli Gynecologic Oncology Group study. Surg Oncol. 2022 Jun;42:101777.  

2. Gemer O, Segev Y, Helpman L, Hag-Yahia N, Eitan R, Raban O, Vaknin Z, Leytes S, Ben Arie A, Amit A, Levy T, Namazov A, Volodarsky M, Ben Shachar I, Atlas I, Bruchim I, Lavie O. Is there a survival advantage in diagnosing endometrial cancer in asymptomatic postmenopausal patients? An Israeli Gynecology Oncology Group study. Am J Obstet Gynecol. 2018 Aug;219(2):181.e1-181.e6

3. Gemer O, Eitan R, Gdalevich M, Mamanov A, Piura B, Rabinovich A, Levavi H, Saar-Ryss B, Halperin R, Finci S, Beller U, Bruchim I, Levy T, Ben-Shachar I, Meirovitz A, Arie AB, Lavie O. Integration of PET/CT into the preoperative evaluation of patients with early cervical cancer does not decrease the proportion of patients with positive lymph nodes found after surgery. Int J Gynecol Cancer. 2014 Oct;24(8):1461-5.

4. Gemer O, Lavie O, Gdalevich M, Eitan R, Mamanov E, Piura B, Rabinovich A, Levavi H, Saar-Ryss B, Halperin R, Finci S, Beller U, Bruchim I, Levy T, Meirovitz A, Shachar IB, Arie AB. Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer. Am J Clin Oncol. 2016 Feb;39(1):37-42.

5. Gemer O, Eitan R, Gdalevich M, Mamanov A, Piura B, Rabinovich A, Levavi H, Saar-Ryss B, Halperin R, Finci S, Beller U, Bruchim I, Levy T, Ben Shachar I, Ben Arie A, Lavie O. Can parametrectomy be avoided in early cervical cancer? An algorithm for the identification of patients at low risk for parametrial involvement. Eur J Surg Oncol. 2013 Jan;39(1):76-80.

6. Gemer O, Gdalevich M, Ravid M, Piura B, Rabinovich A, Gasper T, Khashper A, Voldarsky M, Linov L, Ben Shachar I, Anteby EY, Lavie O. A multicenter validation of computerized tomography models as predictors of non- optimal primary cytoreduction of advanced epithelial ovarian cancer. Eur J Surg Oncol. 2009 Oct;35(10):1109-12.